companydata.dkcompanydata.dk

Merck Life Science A/S: Financial statements 2022

CVR: 20830131

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Merck Life Science A/S (CVR 20830131) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 1,256,087,140 and a net result of DKK 46,001,362 compared with DKK 37,723,717 the year before. That is an increase of 24.5% compared with the year before. The profit margin was 3.7%. Equity in the 2022 report amounted to DKK 166,245,490. The solvency ratio was 71.3%. The company had 20 employees in the financial year.

Revenue
DKK 1,256,087,140
Gross Profit
DKK 80,125,077
Profit/Loss
DKK 46,001,362
Equity
DKK 166,245,490
Total Assets
DKK 233,185,876
Employees
20

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20221.3B80.1M46M166.2M20
20211B69.8M37.7M214.7M16
2020768.2M72.1M41.3M177M16
2019-53.4M27.4M135.7M9
2018-26.9M16.7M67.1M14

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Merck Life Science A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Montserrat Jansa Rodriguez joins the board of Merck Life Science A/SOct 1, 2022

As of October 1, 2022, Montserrat Jansa Rodriguez has joined the board of directors of Merck Life Science A/S.

Montserrat Jansa Rodriguez joins Merck Life Science A/S as adm. dir.Oct 1, 2022

As of October 1, 2022, Montserrat Jansa Rodriguez is registered as adm. dir. of Merck Life Science A/S.

Enrique Álvarez Fernández leaves the board of Merck Life Science A/SSep 30, 2022

As of September 30, 2022, Enrique Álvarez Fernández has left the board of directors of Merck Life Science A/S.

Enrique Álvarez Fernández steps down as adm. dir. of Merck Life Science A/SSep 30, 2022

As of September 30, 2022, Enrique Álvarez Fernández has stepped down as adm. dir. of Merck Life Science A/S.

Merck Life Science A/S: The 2021 annual report is outMay 30, 2022

Merck Life Science A/S has published its annual report for 2021. Revenue came to DKK 1,008,595,819, and the net result was DKK 37,723,717.

About Merck Life Science A/S

Merck Life Science A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1998. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SIGMA-ALDRICH DENMARK A/S and SIGMA-ALDRICH DENMARK ApS. The management consists of Janecke Stokkebokjær Lundring. The board consists of Anders Gerner Petersen (chair), Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka. The company is owned by Merck Life Science N.V. The company has 24 employees (2026). In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. Equity in the 2025 report amounted to DKK 226,078,413.

Source: annual report 2025, Danish Business Authority